Clinical Trials Logo

Fetal Growth Restriction clinical trials

View clinical trials related to Fetal Growth Restriction.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06372938 Active, not recruiting - Clinical trials for Inflammatory Response

Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine Learning Approach

Start date: January 31, 2024
Phase:
Study type: Observational

Fetal growth restriction (FGR) is a serious complication in pregnancy that can lead to various adverse outcomes. It's classified into early-onset (before 32 weeks) and late-onset (after 32 weeks), with late-onset associated with long-term risks like hypoxemia and developmental delays. The study focuses on the role of inflammation in FGR, introducing new blood markers for better understanding and diagnosis. It also addresses the challenges of using advanced diagnostic tools in low-resource settings and explores the use of machine learning to predict FGR based on inflammatory markers, highlighting the potential of artificial intelligence in overcoming these challenges.